Drug Pipeline

Capmatinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-04 NCT05642572
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has…		 date change Primary completion pushed: 2026-05-31 -> 2027-06-30
2026-06-04 NCT05642572
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has…		 date change Completion pushed: 2027-05-31 -> 2028-06-30
Active Studies by Phase
Phase 2
2
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05642572 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has… Recurrent Lung Non-Small Cell Carcinoma Recruiting
NCT03040973 Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to… Advanced Solid Tumors Which Are cMET-dependent Active, Not Recruiting
Phase 1/2
NCT02813135 European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in… Pediatric Cancer Recruiting
NCT05488314 A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
Phase 1
NCT03333343 Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC EGFR-mutant Non-small Cell Lung Cancer Active, Not Recruiting
Sponsors Running Capmatinib Trials
Novartis Pharmaceuticals (2) Gustave Roussy, Cancer Campus, Grand Paris (1) Janssen Research & Development, LLC (1) SWOG Cancer Research Network (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (3) Lung Cancer (2)
Get alerts when Capmatinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free